In Vitro Diagnostics Market Size By Type (Product [Reagents & Kits, Instruments], Service [Software, Testing Services]), By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics), By End-user (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025
Published Date: Aug 2019 | Report ID: GMI2820 | Authors: Sumant Ugalmugle, Rupali Swain
Industry Trends
In Vitro Diagnostics Market size was valued at USD 66.4 billion in 2018 and is expected to witness over 5.5% CAGR from 2019 to 2025. Technological advancements in in-vitro diagnostic tools is the primary factor driving business growth. Focus of business players on introduction of innovative and cutting-edge IVD products will foster the business growth.
Get more details on this report - Request Free Sample PDF
Furthermore, rising investments in the improvement of healthcare sector by government and other organizations will serve to be positive impact rendering factor in the business growth. Numerous initiatives undertaken by government to provide information and education about personalized medication and IVD tools for efficient patient management will spur the market growth. However, excessive cost of in-vitro diagnosis services may hinder industry growth during the forecast period.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2018 | Market Size in 2018: | 66.4 Billion (USD) |
| Historical Data for: | 2014 to 2018 | Forecast Period: | 2019 to 2025 |
| Forecast Period 2019 to 2025 CAGR: | 5.5% | 2025 Value Projection: | 95 Billion (USD) |
| Pages: | 244 | Tables, Charts & Figures: | 352 |
| Geographies covered (17): | U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE | ||
| Segments covered: | Type, Technology, Application, End-user and Region | ||
| Companies covered (15): | Abbott, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Cephied (Danaher Corporation), Grifols, S.A., Johnson & Johnson Services, Inc., Luminex, LivaNova PLC (Sorin), Ortho Clinical Diagnostics, Qiagen, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Thermo Fisher Scientific | ||
| Growth Drivers: |
|
||
| Pitfalls & Challenges: |
|
||
Get more details on this report - Request Free Sample PDF
In Vitro Diagnostics Market, By Type
IVD products segment held around 25% revenue share in 2018. Increasing burden of infectious diseases will surge the demand for in-vitro diagnostic reagents and kits. Focus of business players on developing advanced kits for quick and reliable diagnosis should augment segmental growth.
Service segment is estimated to show robust CAGR of around 5% through 2025. Growing demand for software in diagnostic testing services by clinicians and doctors to diagnose various chronic diseases will boost the market growth.
IVD Market, By Technology
In vitro diagnostics market share from clinical chemistry technology segment was valued at over USD 13.5 billion in 2018 and is estimated to show similar growth. Various applications of clinical chemistry including detection of hormone fluctuations and blood glucose levels will propel overall market demand.
Urinalysis is projected to show more than 5.5% CAGR through 2025. Segment growth is attributable to increasing prevalence of kidney disorders in developed as well as developing economies.
Get more details on this report - Request Free Sample PDF
In Vitro Diagnostics Market, By Application
Cardiology application exceeded USD 11 billion in 2018. Rising prevalence of cardiovascular diseases such as coronary artery disease, arrhythmia and stroke globally will drive demand for in-vitro diagnostics tools.
Oncology segment is projected to witness more than 6% CAGR up to 2025. Availability of advanced home kits such as fecal occult blood test (FOBT) for diagnosis of colon cancer in homecare settings will prove beneficial for market demand.
By End-user
Hospitals segment crossed around USD 20 billion revenue in 2018. Presence of skilled healthcare professionals and technologically progressive medical devices in hospitals will foster business growth over 2019-2025.
Point of care testing segment held considerable revenue share in 2018 and is estimated to show more than 6.5% CAGR during 2019-2025. Point of care diagnostic tests include biosensors, pregnancy kits and glucose meters among others that ensure quick and accurate results. Growing demand for such point of care products and services will thus augment segmental growth.
Regional Outlook
Get more details on this report - Request Free Sample PDF
North America in vitro diagnostics market demand is projected to show around 5.5% CAGR over the analysis timeline. Growing disease burden in the region and awareness among people regarding availability of advanced products will spur regional business size. Moreover, strong foothold of prominent business players will upsurge North America in vitro diagnostics industry growth.
Asia Pacific market share was valued at over USD 13 billion in 2018. Regional growth can be attributed to the on-going trends in the market such as PCR and flow cytometry among others. Growing healthcare expenditure and various healthcare reforms in Asia Pacific will further boost regional business growth.
Competitive Market Share
Some of the notable industry players operating in in vitro diagnostics market share include Johnson & Johnson, Cephied, BioMerieux, Qiagen, Becton Dickinson, Danaher, Abbott, BioRad, Grifols, Luminex, Siemens, Sorin, Thermo Fisher Scientific and Roche Diagnostics. Manufacturers focus on novel product launch, introduction of newer technology within analytical instruments and inorganic strategies to raise their revenue share and sustain market competition.
Frequently Asked Questions (FAQ) :
Buy Now
Need a Discount? Get in touch with us for special pricing
Request DiscountConnect with our sales team
- Phone: 1-302-846-7766
- Toll Free: 1-888-689-0688
- Email: sales@gminsights.com
- Chat With Us: Click here to start
Premium Report Details
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Customer Service
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.
GMIPulse, our report store
We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.